Intravenous thrombolysis for acute ischaemic stroke in the elderly: Data from the Baden-Wuerttemberg stroke registry

European Journal of Neurology

Volumn 23, Issue 1, 2016, Pages 13-20

  Reuter, Björn ^a,b   Gumbinger, C ^c   Sauer, T ^a   Wietholter H ^f   Bruder, I ^d   Rode, S ^d   Ringleb, P A ^c   Kern, R ^a   Hacke, W ^c   Hennerici, M G ^a   Schoser K , ^e   Daffertshofer M , ^f   Diehm C , ^g   Neumaier S , ^h   Muller Jenz B ^f   Drewitz E , ⁱ  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d Rehabilitation and Organization Division   (Germany)

^e Tuttlingen Hospital   (Germany)

^f Klinikum Karlsbad Langensteinbach ^*

^g Klinikum Karlsbad Langensteinbach   (Germany)

^h Medical Services of Health Insurance Freiburg   (Germany)

ⁱ Klinikum   (Germany)

Author keywords

Acute stroke; Age; Epidemiology of stroke; Stroke unit concept; Thrombolytic therapy

Indexed keywords

ALTEPLASE;

AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; FEMALE; GERIATRIC PATIENT; GERMANY; HOSPITAL CARE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANKIN SCALE; VERY ELDERLY; EPIDEMIOLOGY; FIBRINOLYTIC THERAPY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; OUTCOME ASSESSMENT; REGISTER; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; STROKE;

ADMINISTRATION, INTRAVENOUS; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); REGISTRIES; RETROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY;

EID: 84955213509     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12829     Document Type: Article

References (23)

1. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329.
2. Sandercock P, Wardlaw JM, Lindley RI, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the Third International Stroke Trial [IST-3]): a randomised controlled trial. Lancet 2012; 379: 2352-2363.
3. Wardlaw JM, Murray V, Berge E, et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet 2012; 379: 2364-2372.
4. Gumbinger C, Reuter B, Stock C, et al. Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials. BMJ 2014; 348: g3429.
5. Gumbinger C, Reuter B, Wietholter H, et al. A consecutive and prospective stroke database covers the state of Baden-Wuerttemberg with 10.8 million inhabitants in Germany. Neuroepidemiology 2013; 41: 161-168.
6. Chen CI, Iguchi Y, Grotta JC, et al. Intravenous TPA for very old stroke patients. Eur Neurol 2005; 54: 140-144.
7. Berrouschot J, Rother J, Glahn J, Kucinski T, Fiehler J, Thomalla G. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or =80 years) stroke patients. Stroke 2005; 36: 2421-2425.
8. Engelter ST, Reichhart M, Sekoranja L, et al. Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis. Neurology 2005; 65: 1795-1798.
9. van Oostenbrugge RJ, Hupperts RM, Lodder J. Thrombolysis for acute stroke with special emphasis on the very old: experience from a single Dutch centre. J Neurol Neurosurg Psychiatry 2006; 77: 375-377.
10. Toni D, Lorenzano S, Agnelli G, et al. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy. Cerebrovasc Dis 2008; 25: 129-135.
11. Pundik S, McWilliams-Dunnigan L, Blackham KL, et al. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke. J Stroke Cerebrovasc Dis 2008; 17: 266-272.
12. Boulouis G, Dumont F, Cordonnier C, Bodenant M, Leys D, Henon H. Intravenous thrombolysis for acute cerebral ischaemia in old stroke patients >/= 80 years of age. J Neurol 2012; 259: 1461-1467.
13. Mishra NK, Ahmed N, Andersen G, et al. Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive. BMJ 2010; 341: c6046.
14. Mishra NK, Diener HC, Lyden PD, Bluhmki E, Lees KR. Influence of age on outcome from thrombolysis in acute stroke: a controlled comparison in patients from the Virtual International Stroke Trials Archive (VISTA). Stroke 2010; 41: 2840-2848.
15. Ford GA, Ahmed N, Azevedo E, et al. Intravenous alteplase for stroke in those older than 80 years old. Stroke 2010; 41: 2568-2574.
16. Bhatnagar P, Sinha D, Parker RA, Guyler P, O'Brien A. Intravenous thrombolysis in acute ischaemic stroke: a systematic review and meta-analysis to aid decision making in patients over 80 years of age. J Neurol Neurosurg Psychiatry 2011; 82: 712-717.
17. Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014; 384: 1929-1935.
18. GeQiK: Jahresauswertungen. http://www.geqik.de/index.php?id=343 (accessed 29/09/2015).
19. Palm F, Urbanek C, Rose S, et al. Stroke incidence and survival in Ludwigshafen am Rhein, Germany: the Ludwigshafen Stroke Study (LuSSt). Stroke 2010; 41: 1865-1870.
20. Karlinski M, Kobayashi A, Czlonkowska A, et al. Role of preexisting disability in patients treated with intravenous thrombolysis for ischemic stroke. Stroke 2014; 45: 770-775.
21. Alper BS, Malone-Moses M, McLellan JS, Prasad K, Manheimer E. Thrombolysis in acute ischaemic stroke: time for a rethink? BMJ 2015; 350: h1075.
22. Bray BD, Campbell J, Hoffman A, Tyrrell PJ, Wolfe CD, Rudd AG. Stroke thrombolysis in England: an age stratified analysis of practice and outcome. Age Ageing 2013; 42: 240-245.
23. Ovbiagele B, Saver JL. Day-90 acute ischemic stroke outcomes can be derived from early functional activity level. Cerebrovasc Dis 2010; 29: 50-56.